艰难梭菌毒素致病机理的研究进展

摘要/Abstract

摘要： 艰难梭菌是一种革兰氏阳性厌氧芽胞梭菌,是人类肠道感染的主要致病菌,其主要致病因素为毒素A(肠毒素)和毒素B(细胞毒素).毒素A引发细胞损伤后,毒素B即可侵入肠黏膜,引起细胞病变,导致一系列与感染相关的临床表现.同时,艰难梭菌毒素也是引起猪、鸡等畜禽发生腹泻的重要因素,因此探讨艰难梭菌毒素对机体的损伤作用,有利于揭示艰难梭菌的致病机理,为其防控提供理论依据.

关键词: 艰难梭菌; 毒素; 损伤; 致病机理

Abstract: Clostridium difficile is a G⁺ anaerobic and one of the most important pathogenic bacteria in human intestinal infection. Its major pathogenic factors are toxin A (enterotoxin) and toxin B (cytotoxin).After the cell damage caused by toxin A, toxin B can invade the intestinal mucosa, cause cell lesion, lead to cytopathy and a series of clinical manifestations in infection.Meanwhile, Clostridium difficile toxin is also an important factor causing diarrhea in pigs, chickens and other livestock. Exploring the damage of Clostridium difficile toxin to the body is helpful to reveal the pathogenesis of Clostridium difficile, which provides a theoretical basis for prevention and control of Clostridium difficile.

Key words: Clostridium difficile; toxins; damage; pathogenesis

中图分类号:

S852.61⁺6.3

倪孟颖, 吴长德, 杨晶雪. 艰难梭菌毒素致病机理的研究进展[J]. , 2014, 41(12): 263-267.

NI Meng-ying, WU Chang-de, YANG Jing-xue. Research Progress on the Pathogenesis of Clostridium difficile Toxins[J]. , 2014, 41(12): 263-267.

参考文献

1 王宇,郑世民.白细胞介素-8及其在动物疾病发生中的作用[J].中国畜牧兽医,2010,37(3):198～201.
2 王海鹰.艰难梭菌葡萄糖基转移酶基因突变毒素及其在疫苗应用中的研究[D].广州:华南理工大学,2011.
3 尹业师,王欣.人艰难梭菌感染的致病机制与防治策略研究进展[J].现代生物医学进展,2013,13(26):5155～5160.
4 许方方,胡玉苗,冉珊珊,等.艰难梭菌毒素及致病基因的研究进展[J].动物医学进展,2013,34(7):100～103.
5 李先平,李文革,王晶,等.中美艰难梭菌A^－B⁺株毒力编码区域转录及B毒素表达的研究[J].中国感染控制杂志,2014,13(2):65～70.
6 苏文金.肠道菌群对艰难梭菌拮抗作用的动物模型研究[J].厦门大学学报自然科学版,1988,27(5):578～582.
7 张建华,宋铁牛,李斌,等.艰难梭菌A毒素对食管癌干细胞损伤的研究[J].中国现代医学杂志,2013,25:16～19.
8 杨雪妹,吴允孚.艰难梭菌的生物学特性与实验室诊断[J].中国感染与化疗杂志,2013a,13(3):232～234.
9 杨雪妹,吴允孚.艰难梭菌感染的流行病学和诊治进展[J].中国感染与化疗杂志,2013b,13(4):312～316.
10 曹波,李先平,程颖.艰难梭菌引起抗感染免疫的主要致病因子及其基因功能的研究进展[J].免疫学杂志,2013,29(4):357～360.
11 章黎华,董丹凤,江岑,等.院内感染艰难梭菌的毒素检测及核糖体分型研究[J].上海交通大学学报(医学版),2012,32(11):1436～1440.
12 程慧,李芳.IL-8与结直肠癌[J].大连医科大学学报,2014,36(1):95～97.
13 董妍玲,潘学武.细菌S-layer 蛋白的研究新进展[J].化学与生物工程,2010,27(2):11～14.
14 傅思武,毛敏燕,苏露,等.艰难梭菌B毒素的纯化及其生物学特性[J].中国生物制品学杂志,2011,24(10):1217～1220.
15 薛超辉,张兰威,王淑梅,等.益生菌预防与治疗艰难梭菌腹泻的研究进展[J].食品工业科技,2013,22:358～362.
16 Bishop A L,Hall A.Rho GTPases and their effector proteins[J].Biochem,2000,348(2):241～255.
17 Burridge K,Wennerberg K.Rho and Rac take center stage[J].Cell,2004,116:167～179.
18 Davies N L,Compson J E,Mackenzie B,et al.A mixture of functionally oligoclonal humanized monoclonal antibodies that neutralize Clostridium difficile TcdA and TcdB with high levels of in vitro potency shows in vivo protection in a hamster infection model[J].Clinical and Vaccine Immunology,2013,20(3):377～390.
19 Dineen S S,Villapakkam A C,Nordman J T,et al.Repression of Clostridium difficile toxin gene expression by CodY[J].Mol Microbilo,2007,66:206～219.
20 Donta S T,Sullivan N,Wilkins T D.Differential effects of Clostridium difficile toxins on tissuecultured cells[J].Clin Microbiol,1982,15:1157～1158.
21 Dupuy B,Govind R,Antunes A,et al.Clostridium difficile toxin synthesis is negatively regulated by TcdC[J].Journal of Medical Microbiology,2008,57:685～689.
22 Geric B,Carman R J,Rupnik M,et al.Binary toxin-producing,large clostridial toxin-negative Clostridium difficile strains are enterotoxic but do not cause disease in hamsters[J].J Infect Dis,2006,193:1143～1150.
23 Govind R,Dupuy B.Secretion of Clostridium difficile toxins A and B requires the Holin like protein TcdE[J].PLoS Pathogens,2012,8(6):1～14.
24 Hundsberger T,Braun V,Weidmann M,et al.Transcription analysis of the genes tcdA-E of the pathogenicity locus of Clostridium difficile[J].Eur J Biochem,1997,244(3):735～742.
25 Johnson S,Samore M H,Farrow K A,et al.Epidemics of diarrhea cause by a clindamycin-resistant strain of Clostridium difficile in four hospitals[J].N Engl J Med,1999,341(22):1645～1651.
26 Kelly C P,Becker S,Linevsky J K,et al.Neutrophil recruitment in Clostridium difficile toxin A enteritis in the rabbit[J].Journal of Clinical Investigation,1994,93:1257～1265.
27 Kolling G L, Wu M, Warren C A,et al.Lactic acid production by Streptococcus thermophilus alters Clostridium difficile infection and in vitro toxin A production[J].Gut Microbes,2012,3(6):523～529.
28 Koon H W,Shih D Q,Hing T C,et al.Human monoclonal antibodies against Clostridium difficile toxins A and B inhibit inflammatory and histologic responses to the toxins in human colon and peripheral blood monocytes[J].Antimicrobial Agents and Chemotherapy,2013,58(7):3124～3133.
29 Kuehne S A,Cartman S T,Heap J T,et al.The role of toxin A and toxin B in Clostridium difficile infection[J].Nature,2010,467:711～714.
30 Lyras D,O'Connor J R,Howarth P M,et al.Toxin B is essential for virulence of Clostridium difficile[J].Nature,2009,458(7242):1176～1179.
31 Pruitt R N,Lacy D B.Toward a structural understanding of Clostridium difficile toxins A and B[J].Cellular and Infection Microbiology,2012,2(28):1～14.
32 Riegler M,Sedivy R,Pothoulaki C,et al.Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro[J].Clin Invest,1995,95:2004～2011.
33 Santos A A,Braqa-Neto M B,Oliveira M R,et al.Glutamineand alanyl-glutamine increase RhoA expression and reduce Clostridium difficile toxin-A-induced intestinal epithelial cell damage[J].Bio Med Research International,2012,2013:1～13.
34 Spigaglia P,Mastrantonio P.Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates[J].American Society for Microbiology,2002,40(9):3470～3475.
35 Steele J,muherjee J,Parry N,et al.Antibody against TcdB,but not TcdA,prevents development of gastrointestinal and systemic Clostridium difficile disease[J].The Journal of Infectious Diseases,2013,207:323～331.
36 Warren C A,Calabress G M,Li Y,et al.Effects of adenosine A₂A receptor activation and alanyl-glutamine in Clostridium difficile toxin-induced ileitis in rabbits and cecitis in mice[J].BMC Infectious Diseases,2012,12:13.
37 Wullt M,Norén T,Ljungh A,et al.IgG antibody response to toxins A and B in patients with Clostridium difficile infection[J].Clinical and Vaccine Immunology,2012,19(9):1552～1554.

[1]	陈楷文, 赵云娇, 王磊, 张剑搏, 马玉红, 吴国芳. 不同氧浓度下猪睾丸间质细胞转录组分析[J]. 中国畜牧兽医, 2023, 50(6): 2185-2195.
[2]	李灿, 李楚楚, 曾维, 张宁, 纪春晓, 陈韬. 猪RegⅢγ蛋白的重组表达及功能研究[J]. 中国畜牧兽医, 2023, 50(6): 2414-2426.
[3]	宋越, 苏胜杰, 张帆, 白帆, 戴伶俐, 王娜, 王大伟, 杨茜雯, 赵世华, 张月梅. 溶血性曼氏杆菌截短型白细胞毒素的原核表达及多克隆抗体制备[J]. 中国畜牧兽医, 2023, 50(6): 2479-2486.
[4]	张金武, 魏紫, 冀禹彤, 吴昌旭, 李振民, 韦英益, 胡庭俊, 于美玲. A型产气荚膜梭菌诱导黄羽肉鸡肠道氧化应激和炎性损伤研究[J]. 中国畜牧兽医, 2023, 50(5): 2069-2081.
[5]	郭红伟, 蔡永超, 樊春光, 郝凯旋, 常娟, 王平, 刘超齐, 尹清强. 复合生物解毒剂在人工胃肠液中对黄曲霉毒素B₁降解率的影响[J]. 中国畜牧兽医, 2023, 50(4): 1395-1403.
[6]	黄小倩, 原俊朝, 刘金河, 邹辉, 顾建红, 袁燕, 刘学忠, 刘宗平, 卞建春. 和厚朴酚对镉致鸡肾脏损伤的保护作用[J]. 中国畜牧兽医, 2023, 50(3): 1007-1015.
[7]	郑小惠, 刘坤, 辛航阔, 谢青青, 朱婷. 线粒体自噬在神经退行性疾病中调控的研究进展[J]. 中国畜牧兽医, 2023, 50(2): 490-499.
[8]	何炎峻, 金圣子, 王爽, 柳可欣, 刘云. 薯蓣皂苷元对顺铂诱导大鼠肾损伤的缓解作用[J]. 中国畜牧兽医, 2022, 49(9): 3633-3642.
[9]	唐庆凤, 李玲, 黄加祥, 方文远, 农皓如, 唐艳, 陆呈委, 韦盘秋, 冯玲. 广西地区不同饲养模式及不同季节水牛奶霉菌毒素污染状况调查[J]. 中国畜牧兽医, 2022, 49(9): 3665-3675.
[10]	张玉珍, 黄敏仪, 陈可纯, 蔡永铭, 杨祎琦. 高脂高果糖饮食对老年小鼠视网膜形态结构的影响[J]. 中国畜牧兽医, 2022, 49(7): 2515-2522.
[11]	沈幸玲, 丁康宁, 王幽丛, 张易安, 刘逸雷, 刘涵笑, 唐陆平, 何永明. 火炭母缓解鼠伤寒沙门菌致小鼠肝损伤的机制研究[J]. 中国畜牧兽医, 2022, 49(7): 2768-2777.
[12]	张振宇, 王勇. 乳与乳制品中黄曲霉毒素检测研究进展[J]. 中国畜牧兽医, 2022, 49(7): 2820-2830.
[13]	安志霞, 潘阳阳, 范碧玥, 马小燕, 叶得河, 张治杰, 邱山桐, 姚亚乐, 王萌. 基于网络药理学研究连翘叶提取物通过AMPK抗恩诺沙星诱导肝损伤的作用[J]. 中国畜牧兽医, 2022, 49(6): 2347-2361.
[14]	王爽, 刘星尧, 贾昊天, 刘云. 硫化氢对顺铂致犬肾脏氧化损伤及炎症的缓解作用[J]. 中国畜牧兽医, 2022, 49(6): 2376-2384.
[15]	王奔, 袁帅, 郑怡, 张宏玲. JNK抑制剂对仔猪肝细胞药物性损伤的缓解作用及其机理[J]. 中国畜牧兽医, 2022, 49(5): 1888-1894.